We focus on FDA-approved GLP-1 care pathways.
My prior authorization for a GLP-1 was denied. What are the most common reasons?
This sits after a prescription and prior authorization request, when reviewing an insurer’s coverage decision.
A prior authorization denial usually means the plan decided that the request did not meet one or more of its coverage requirements. Common issues can include the medication not being a covered benefit, the request not matching the plan’s covered use, missing information, or a requirement to try another covered medication first.
Some plans also apply utilization rules such as prior authorization, step therapy, quantity limits, or other restrictions. CMS lists these types of prescription coverage requirements. Requirements differ by plan, so a denial from one insurer does not establish what another plan will decide.
Check the denial notice for the specific reason, the plan rule involved, and the deadline or instructions for resubmission or appeal. For Medicare Part D, CMS says a coverage determination notice should identify the applicable coverage rule and explain the available appeal process. See CMS guidance on prescription drug coverage determinations.
You can ask the prescribing office whether it can correct or add information to the request, and ask the insurer what documentation is required. This page does not predict approval or recommend a particular medication or provider.